quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:10:09·13d
SECFiling
Royalty Pharma plc logo

SEC Form DEF 14A filed by Royalty Pharma plc

RPRX· Royalty Pharma plc
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • RPRX
    Royalty Pharma plc
    Health Care

Recent analyst ratings

  • Jan 30UpdateUBS$49.00
  • Sep 30UpdateGoldman$42.00
  • May 16UpdateMorgan Stanley$51.00
  • Jun 3UpdateUBS$28.00
  • Jun 14UpdateUBS$47.00
  • May 13UpdateScotiabank$53.00

Related

  • PR2d
    Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
  • PR6d
    Royalty Pharma Declares Second Quarter 2026 Dividend
  • PR8d
    Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
  • SEC10d
    SEC Form 8-K filed by Royalty Pharma plc
  • SEC13d
    SEC Form DEFA14A filed by Royalty Pharma plc
  • INSIDER21d
    SEC Form 4 filed by Coyne Terrance P.
  • SEC22d
    SEC Form 13F-NT filed by Royalty Pharma plc
  • INSIDER23d
    SEC Form 4 filed by Bassler Bonnie L
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022